Myriad Genetics buy melinda
Start price
10.09.17
/
50%
€32.62
Target price
22.01.18
€42.00
Performance (%)
18.73%
End price
22.01.18
€38.73
Summary
This prediction ended on 22.01.18 with a price of €38.73. The prediction had a final performance of 18.73%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Myriad Genetics | 7.563% | 7.563% | 28.000% | -3.759% |
iShares Core DAX® | -0.598% | 0.645% | 10.813% | 15.396% |
iShares Nasdaq 100 | -3.290% | -4.193% | 23.772% | 40.773% |
iShares Nikkei 225® | -0.796% | -0.582% | 8.390% | 8.288% |
iShares S&P 500 | -1.164% | -0.857% | 23.003% | 41.152% |
Comments by melinda for this prediction
In the thread Myriad Genetics diskutieren
$
Myriad Genetics, Inc.
GeneSight® Gezeigte Deutlich zu generalisierten Angststörung Ansprechen auf die Behandlung verbessern Statistisch gesehen und verringern Benzodiazepinkonsum
(Vom Mitglied beendet)